LINC02126 is a potential diagnostic, prognostic and immunotherapeutic target for lung adenocarcinoma
Article in BMC Pulmonary Medicine (November 2022)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma
Article in World Journal of Surgical Oncology (June 2022)
UCHL1 acts as a potential oncogene and affects sensitivity of common anti-tumor drugs in lung adenocarcinoma
Article in World Journal of Surgical Oncology (May 2022)